Skip to main content

Advertisement

SpringerLink
Log in

Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer

  • Letter to the Editor
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol. 2012;259(7):1383–9.

    Article  PubMed  Google Scholar 

  2. Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what's certain, what's new? Pract Neurol. 2011;11(3):136–44.

    Article  CAS  PubMed  Google Scholar 

  3. Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol. 2006;63(10):1475–8.

    Article  PubMed  Google Scholar 

  4. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006;354(9):980–2.

    Article  CAS  PubMed  Google Scholar 

  5. Tlemsani C, Mir O, Boudou-Rouquette P, Huillard O, Maley K, Ropert S, Coriat R, Goldwasser F. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. Target Oncol. 2011;6(4):253–8.

    Article  PubMed  Google Scholar 

  6. Seet RC, Rabinstein AA. Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment. QJM. 2012;105(1):69–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. American University Medical Center, POB 113-6044/C-27, Beirut, Lebanon

    R. Sawaya, W. Radwan & S. Hammoud

Authors
  1. R. Sawaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Radwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Hammoud
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Sawaya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sawaya, R., Radwan, W. & Hammoud, S. Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer. Med Oncol 31, 831 (2014). https://doi.org/10.1007/s12032-013-0831-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0831-1

Keywords

Search

Navigation